2020
DOI: 10.1053/j.jvca.2020.02.029
|View full text |Cite
|
Sign up to set email alerts
|

Precision Cardiac Anesthesia: Welcome Aboard!

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
9
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6

Relationship

5
1

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 14 publications
0
9
0
Order By: Relevance
“…Preoperative elevation of MHAR independently predicted postoperative AKI in the retrospective evaluation of our diabetic patients undergoing OPCABG. While the novel ratio concocts the nutritional and inflammatory predisposition and can potentially assist risk stratification and individualization 37,38 of targeted therapy, future prospective studies are warranted to validate the initial encouraging findings across diverse clinical settings.…”
Section: Discussionmentioning
confidence: 99%
“…Preoperative elevation of MHAR independently predicted postoperative AKI in the retrospective evaluation of our diabetic patients undergoing OPCABG. While the novel ratio concocts the nutritional and inflammatory predisposition and can potentially assist risk stratification and individualization 37,38 of targeted therapy, future prospective studies are warranted to validate the initial encouraging findings across diverse clinical settings.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, the research community is not new to such examples (premature embracement of recombinant human activated protein-C, etc.) with these previous experiences only highlighting the need of maintaining a high quality standard of evidence for moving practice forward [4] , [5] , [6] . In this context, the FDA has recently outlined a regulatory document of guidance on the conduct of clinical trials related to the public health emergency of COVID-19 [7] .…”
mentioning
confidence: 97%
“…The precision medicine slogan: “ One-size-does-not-fit-all ” embraces the commonplace heterogeneity observed in the treatment effects, perioperative complications and associated outcomes. [ 8 9 ] The proponents of the notion opine that EBM by nature regards treatment at a population level with minimal individualistic considerations and highlight the importance of personalizing clinical medicine. Nevertheless, the overarching premise to make precision medicine evidence-based is substantially challenging given a patient is much more than a set of covariates and incurs multipronged difficulties in the terms of investigation, knowledge-acquisition, education, interpretation, and dissemination of multilevel data, from cellular level to environment and lifestyle, for the ever-diversifying patient population.…”
mentioning
confidence: 99%
“…To conclude, much or most of the practice variability in clinical medicine stems from the subtle differences among the patients. [ 7 8 9 ] Therefore, personalized management is appreciated well even in the era of EBM aimed at improving patient outcomes as it does not annihilate intuition, clinical expertise, and reasoning physiology as the ground for decision-making while accounting for the systematic evaluation of the evidence. In fact, distant from the dogma of EBM and precision medicine being dichotomous, an intuitive “open-mind” can complement both to practice evidence-based precision medicine in a unified pluralistic health care model, particularly relevant in the perioperative management of high-risk surgical cohort.…”
mentioning
confidence: 99%